The Clinical Trial Unit at St John of God Subiaco Hospital is committed to ongoing research of cancer treatment and outcomes, ensuring our patients receive the most advanced contemporary treatment as well as contributing to the wider body of knowledge in relation to cancer.
The importance of clinical trials
- Oncology clinical trials are crucial in advancing cancer treatment and improving patient outcomes. These trials are essential for testing new therapies, drugs and treatment regimens that could potentially offer better results than current standard options.
- By enrolling patients in clinical trials, researchers can evaluate the effectiveness, safety and side effects of novel treatments in real-world settings. The data collected from these trials not only aids in the development of targeted therapies but also helps personalise cancer treatment, tailoring it to the specific needs of individuals.
- Oncology clinical trials also provide patients with access to cutting-edge therapies that might not yet be available through conventional care, offering hope for better survival rates and improved quality of life.
What we focus on
The Subiaco Clinical Trial Unit has a strong record of providing vital treatment opportunities for patients consistent with the hospital’s clinical service provision.
Areas of focus include pancreatic, ovarian, endometrial, breast, lung, upper gastrointestinal, prostate, renal and colorectal cancers. The unit engages in commercially-sponsored, investigator-initiated and cooperative research group trials, from early-phase first-in-human, to late phase trials, with a specific focus on areas of unmet need. Currently, 47 trials are active in the unit, and strong interest continues to be received from commercial sponsors and external collaborators to participate in future trials.
The treatment options available via clinical trials provide hope to patients and allow St John of God Subiaco Hospital to be at the forefront of new treatment discoveries.